NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Max Healthcare Institute Limited (NSE: MAXHEALTH)
MAXHEALTH Technical Analysis
3
As on 16th Apr 2025 MAXHEALTH SHARE Price closed @ 1077.50 and we RECOMMEND Buy for LONG-TERM with Stoploss of 980.87 & Buy for SHORT-TERM with Stoploss of 1058.53 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MAXHEALTHSHARE Price
Open | 1084.00 | Change | Price | % |
High | 1088.00 | 1 Day | 3.40 | 0.32 |
Low | 1067.00 | 1 Week | -45.65 | -4.06 |
Close | 1077.50 | 1 Month | 86.80 | 8.76 |
Volume | 1947807 | 1 Year | 259.55 | 31.73 |
52 Week High 955.80 | 52 Week Low 419.15 |
NSE INDIA Most Active Stocks
IDEA | 7.27 | -0.68% |
IREDA | 176.39 | 5.64% |
EASEMYTRIP | 12.19 | -8.55% |
YESBANK | 17.87 | 2.00% |
GTLINFRA | 1.49 | 1.36% |
NBCC | 95.80 | 6.72% |
TATASTEEL | 136.97 | 0.41% |
IDFCFIRSTB | 63.32 | 2.24% |
SUZLON | 54.34 | -0.06% |
INDUSINDBK | 788.25 | 7.11% |
NSE INDIA Top Gainers Stocks
NSE INDIA Top Losers Stocks
JTLIND | 66.98 | -17.19% |
IITL | 208.79 | -10.00% |
RAJTV | 58.32 | -10.00% |
EASEMYTRIP | 12.19 | -8.55% |
ZYDUSLIFE | 822.10 | -6.91% |
ALMONDZ | 24.08 | -6.74% |
UMAEXPORTS | 80.08 | -6.37% |
BALUFORGE | 599.90 | -5.68% |
CUBEXTUB | 80.71 | -5.39% |
KESORAMIND | 3.32 | -5.14% |
MAXHEALTH Daily Charts |
MAXHEALTH Intraday Charts |
Whats New @ Bazaartrend |
MAXHEALTH Free Analysis |
|
MAXHEALTH Important Levels Intraday
RESISTANCE | 1117.97 |
RESISTANCE | 1104.99 |
RESISTANCE | 1096.97 |
RESISTANCE | 1088.95 |
SUPPORT | 1066.06 |
SUPPORT | 1058.03 |
SUPPORT | 1050.01 |
SUPPORT | 1037.03 |
MAXHEALTH Target April 2025
4th UP Target | 1432.68 |
3rd UP Target | 1286.89 |
2nd UP Target | 1196.78 |
1st UP Target | 1106.67 |
1st DOWN Target | 849.53 |
2nd DOWN Target | 759.42 |
3rd DOWN Target | 669.31 |
4th DOWN Target | 523.52 |
MAXHEALTH Weekly Target
4th UP Target | 1252.81 |
3rd UP Target | 1200.37 |
2nd UP Target | 1167.96 |
1st UP Target | 1135.54 |
1st DOWN Target | 1043.06 |
2nd DOWN Target | 1010.64 |
3rd DOWN Target | 978.23 |
4th DOWN Target | 925.79 |
MAXHEALTH Target2025
4th UP Target | 2447.18 |
3rd UP Target | 2024.16 |
2nd UP Target | 1762.68 |
1st UP Target | 1501.2 |
1st DOWN Target | 755.1 |
2nd DOWN Target | 493.62 |
3rd DOWN Target | 232.14 |
4th DOWN Target | -190.88 |
Max Healthcare Institute Limited ( NSE INDIA Symbol : MAXHEALTH )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
MAXHEALTH Synopsis Technicals View
50 Day EMA |
N/A (Short Term) |
N/A | |
100 Day EMA | N/A (Mid Term) | N/A | |
200 Day EMA | N/A (Long Term) | N/A | |
MACD (12 26 9) | N/A | N/A | |
RSI (14) | N/A | N/A | |
MFI (14) | N/A | N/A | |
CCI (20) | N/A | N/A | |
WILLIAM %R (14) | N/A | N/A | |
ADX (14) | N/A | N/A | |
PSAR | N/A | N/A | |
10 Day Avg Volume | N/A |
MAXHEALTH Other Details
Segment | EQ | |
Market Capital | 0.00 | |
Sector | ||
Industry | ||
Offical website | > echo $website ; ?> |
MAXHEALTH Address
![]() |
MAXHEALTH Latest News
MAXHEALTH Business Profile
N/A
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service